glutathione and triple negative breast cancer Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven metalloimmunotherapy for triple-negative | Journal of Nanobiotechnology GSTP1 Is a Driver of
GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect Involvement of glutathione peroxidases in the occurrence and development of breast cancers Journal of Translational Medicine Springer Nature Link Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple negative breast cancer treatment ScienceDirect
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



